ES493029A0 - Procedimiento para la obtencion de octapeptidos ciclicos - Google Patents

Procedimiento para la obtencion de octapeptidos ciclicos

Info

Publication number
ES493029A0
ES493029A0 ES493029A ES493029A ES493029A0 ES 493029 A0 ES493029 A0 ES 493029A0 ES 493029 A ES493029 A ES 493029A ES 493029 A ES493029 A ES 493029A ES 493029 A0 ES493029 A0 ES 493029A0
Authority
ES
Spain
Prior art keywords
octapeptides
procedure
obtaining cycle
cycle
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES493029A
Other languages
English (en)
Other versions
ES8105698A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES493029A0 publication Critical patent/ES493029A0/es
Publication of ES8105698A1 publication Critical patent/ES8105698A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ES493029A 1979-07-04 1980-07-02 Procedimiento para la obtencion de octapeptidos ciclicos Expired ES8105698A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH624379 1979-07-04
CH113580 1980-02-12

Publications (2)

Publication Number Publication Date
ES493029A0 true ES493029A0 (es) 1981-06-16
ES8105698A1 ES8105698A1 (es) 1981-06-16

Family

ID=25686753

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493029A Expired ES8105698A1 (es) 1979-07-04 1980-07-02 Procedimiento para la obtencion de octapeptidos ciclicos

Country Status (17)

Country Link
US (1) US4328214A (es)
EP (1) EP0023192B1 (es)
KR (1) KR840000927B1 (es)
AU (1) AU539499B2 (es)
CA (1) CA1148146A (es)
DD (1) DD152543A5 (es)
DE (1) DE3067252D1 (es)
DK (1) DK287680A (es)
ES (1) ES8105698A1 (es)
FI (1) FI802079A (es)
GR (1) GR69319B (es)
HU (1) HU188081B (es)
IE (1) IE49995B1 (es)
IL (1) IL60474A (es)
NO (1) NO152092C (es)
NZ (1) NZ194227A (es)
PT (1) PT71490A (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
GB8318552D0 (en) * 1983-07-08 1983-08-10 Sandoz Ltd Organic compounds
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US5411951A (en) * 1984-10-04 1995-05-02 Monsanto Company Prolonged release of biologically active somatotropin
US5474980A (en) * 1984-10-04 1995-12-12 Monsanto Company Prolonged release of biologically active somatotropins
ES8702440A1 (es) * 1984-10-04 1986-12-16 Monsanto Co Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.
US5086041A (en) * 1984-10-04 1992-02-04 Monsanto Company Methods of using prolonged release somatotropin compositions
US4684716A (en) * 1984-12-14 1987-08-04 Smithkline Beckman Corporation Polypeptide intermediates
US4597901A (en) * 1984-12-14 1986-07-01 Smithkline Beckman Corporation β-indolylalanyl or β-indolylglycinyl vasopressin antagonists
US4719199A (en) * 1984-12-14 1988-01-12 Smithkline Beckman Corporation Diuretic compositions and methods of producing diuresis
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
FR2663934B1 (fr) * 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
GB9502540D0 (en) * 1995-02-09 1995-03-29 Zeneca Ltd Compounds
GB9618952D0 (en) * 1996-09-11 1996-10-23 Sandoz Ltd Process
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
EP0981363B1 (en) 1997-05-13 2003-07-30 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin agonists for decreasing body weight
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
EP0980253B1 (en) * 1997-05-13 2004-03-31 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x
EP0981364B1 (en) * 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Method and compositions for treating hyperlipidemia
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
AU1602100A (en) 1998-11-25 2000-06-13 Warner-Lambert Company Improved gamma amino butyric acid analogs
HUP0400245A3 (en) 2001-06-08 2012-09-28 Ipsen Pharma Sas Somatostatin-dopamine chimeric analogs and pharmaceutical compositions containing them
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CA2523197C (en) 2003-04-22 2016-05-24 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide vectors
AR044852A1 (es) * 2003-06-24 2005-10-05 Novartis Ag Una composicion farmaceutica para la administracion parenteral que comprende un analogo de somatostatina
JP5728380B2 (ja) 2008-06-12 2015-06-03 シンタクシン リミテッドＳｙｎｔａｘｉｎ Ｌｉｍｉｔｅｄ 神経内分泌疾患の抑制
BRPI0915142A8 (pt) 2008-06-12 2018-01-02 Syntaxin Ltd Polipeptídeos, ácido nucleico e usos dos mesmos
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
DK3007704T3 (da) 2013-06-13 2021-03-29 Antisense Therapeutics Ltd Kombinationsterapi til akromegali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875207A (en) * 1967-01-25 1975-04-01 Ciba Geigy Corp Process for the temporary protection of amino groups in peptide syntheses
US3944590A (en) * 1967-01-25 1976-03-16 Ciba-Geigy Corporation Process for the temporary protection of amino groups in peptide syntheses
US3725380A (en) * 1969-04-05 1973-04-03 Hoechst Ag Method of synthesizing peptides in the presence of a carbodiimide and a 1-hydroxy-benzotriazole
CH577464A5 (es) * 1972-09-22 1976-07-15 Ciba Geigy Ag
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden

Also Published As

Publication number Publication date
KR840000927B1 (ko) 1984-06-29
IL60474A0 (en) 1980-09-16
NO802009L (no) 1981-01-05
IL60474A (en) 1983-10-31
IE49995B1 (en) 1986-01-22
AU6007380A (en) 1981-01-15
EP0023192A1 (de) 1981-01-28
PT71490A (de) 1980-08-01
HU188081B (en) 1986-03-28
IE801371L (en) 1981-01-04
DD152543A5 (de) 1981-12-02
NO152092B (no) 1985-04-22
KR830003401A (ko) 1983-06-20
NO152092C (no) 1985-07-31
ES8105698A1 (es) 1981-06-16
NZ194227A (en) 1983-05-31
DE3067252D1 (en) 1984-05-03
GR69319B (es) 1982-05-14
AU539499B2 (en) 1984-10-04
DK287680A (da) 1981-01-05
US4328214A (en) 1982-05-04
FI802079A (fi) 1981-01-05
EP0023192B1 (de) 1984-03-28
CA1148146A (en) 1983-06-14

Similar Documents

Publication Publication Date Title
ES493029A0 (es) Procedimiento para la obtencion de octapeptidos ciclicos
ES493633A0 (es) Procedimiento para la obtencion de muramilpeptidos
MX147446A (es) Procedimiento mejorado para la etilacion de benceno
ES496848A0 (es) Procedimiento para la obtencion de azoliloxi-carboxil-n- oxiamidas
AR222778A1 (es) Procedimiento para la obtencion de hentriacontapeptidos
MX149569A (es) Procedimiento mejorado para la obtencion de tetrafluoroetano
ES497974A0 (es) Procedimiento para la obtencion de un octapeptido ciclico
ES495214A0 (es) Procedimiento para la obtencion de nuevos derivados defor- miltilosinos
ES493770A0 (es) Procedimiento para la obtencion de poliarilensulfuros
MX147440A (es) Procedimiento mejorado para la obtencion de metacroleina
ES493330A0 (es) Procedimiento para la obtencion de nikkomicinas de efecto pesticida
MX147734A (es) Procedimiento mejorado para la obtencion de dimetil-eter
ES491686A0 (es) Procedimiento para la obtencion de tiovinil-3 cefalosporinas
ES493771A0 (es) Procedimiento para la obtencion de poliarilensulfuros
MX5352E (es) Procedimiento mejorado para la obtencion de alquenilsuccinimidas
ES496650A0 (es) Procedimiento para la obtencion de alquilureas
ES491689A0 (es) Procedimiento para la obtencion de cefalosporinas
AR213555A1 (es) Procedimiento para la preparacion de 2,5-diclorofenol
MX148160A (es) Procedimiento mejorado para la obtencion de alcoxisilanos
AR226694A1 (es) Procedimiento para obtener nuevos derivados de antraciclina
MX148906A (es) Procedimiento para la obtencion de dihidroxipoliuretanos
MX7642E (es) Procedimiento para preparar la 1-ciclo-hexenilmentil-2-cloroetil pirrolidina
ES488717A0 (es) Procedimiento para la obtencion de derivados de pirazol
ES496334A0 (es) Procedimiento para la obtencion de 5-ciano-5h-dibenz(b,f)- azepina
ES490988A0 (es) Procedimiento para la obtencion de butirolactona